1. Introduction {#sec1}
===============

Due to the improved imaging techniques and chemotherapy regimens nowadays, limb sparing procedures become the mainstay of treatment of primary bone tumors \[[@B1]\]. Unfortunately, the long term results of classic long-stem endoprosthetic reconstructions (cemented or uncemented) are poor due to loosening and/or stress shielding, displaying a survival rate of 83 percent at five years and only 67 percent at ten years \[[@B2]\]. As the patient population is generally young, major revisions are required to restore a stable fixation, associated with additional bone loss \[[@B3], [@B4]\]. Stems with a coated collar allowing active bone ingrowth proved to provide a better fixation on the long term \[[@B5]--[@B7]\]. Dynamic compression fixation (Compress) of tumor prostheses was proposed as an alternative to long stems, aiming to improve the long term survivorship of the implant through active osseointegration. By using a short traction bar the ongoing compressive force generated by Belleville washers stimulates osseointegration at the bone-prosthetic interface \[[@B10], [@B11]\] and promotes hypertrophy of the loaded bone. In literature currently no radiographic scoring system is available to evaluate the ingrowth and the bone hypertrophy in a straightforward way. For instance, the ISOLS radiographic scoring system is not applicable to this kind of fixation \[[@B12]\]. For the purpose of easier and proper radiologic evaluation and comparison, a new staging method was developed.

2. Study Design and Methods {#sec2}
===========================

Between 2006 and 2014 27 patients with distal third femoral replacements only were included in this study. All interventions were performed in a single university hospital by the same orthopedic surgeon (GS). A reconstruction prosthesis (OSS, Biomet, Warsaw, Indiana) was used in all patients, fixed to the bone by a Compress device. All patients had an initial resection of a bone tumor (19 bone sarcomas, 2 giant cell tumors of bone, and 2 soft tissue sarcomas affecting the bone). Ten patients (group 1) did not receive chemotherapy at least 1 year before the surgical intervention. Sixteen patients (group 2) received neoadjuvant and adjuvant chemotherapy according to the EURAMOS \[[@B13]\] and one Euro-Ewing protocol \[[@B14]\].

The treatment was coordinated by a multidisciplinary oncological team specialized in sarcoma treatment. Demographics and diagnoses are presented in [Table 1](#tab1){ref-type="table"}.

The mean follow-up for patients enrolled in the study was 36 months (median 34 months, range 15--66 months). During the study one patient had an amputation because of full thickness flap failure at 2 months. Another one developed early postop infection treated with debridement and irrigation. The age distribution was 9--68 years mean 27; there were 15 females and 12 males. Data were collected up to 18 months postoperatively. The mean resection length was 15 cm (median 16 cm, range 8--26 cm). Only cases of femoral osseointegration were included, in [Table 2](#tab2){ref-type="table"}.

Radiological assessment (standard AP and lateral view) took place immediately after the operation. Afterwards office visits were scheduled for clinical evaluation and radiographs at 6 weeks, 3, 6, 9, 12, 15, and 18 months after surgery. No patients were recalled specifically for the study. The radiographs were taken before the consultation and afterwards coded without names and dates by the study nurse. The radiographic evaluation was performed independently by two orthopedic surgeons according to the new staging system and was repeated three times.

For the staging system four radiological stages were defined: stage 0: immediate postoperative status, no ingrowth, or noncalcified callus; stage 1: early mineralization, calcified callus; stage 2: mature mineralization; and stage 3: hypertrophy at the level of the pins, as in [Figure 1](#fig1){ref-type="fig"}.

The Medical Ethics Committee granted approval for the study and informed consent was obtained from all the patients or their parents.

2.1. Surgical Technique {#sec2.1}
-----------------------

After en bloc removal of the tumor, a standard technique for prosthetic reconstruction was used as recommended by the manufacturer \[[@B10], [@B11]\]. Shortly, during the preparation of the diaphyseal bone special attention was taken to protect the blood supply in the bone-prosthesis interface region by minimal reaming and protecting the periosteal membrane. Subsequently the anchor plug and traction bar were secured to the cortical bone via transverse pins. The spindle containing the Belleville washers was attached to the traction bar by means of a nut, resulting in a compression of the spindle to the bone. The compression force used, depending on the cortical width, varied between 600 and 800 lb. (181--363 kg) and serves to promote bone ingrowth at the bone-prosthetic interface and to induce bone hypertrophy according to Wolff\'s Law. Two or three antirotational pins were used to avoid loosening of the device by rotational forces. These pins were available since the end of 2011, not before.

Rehabilitation encompassing active-assisted and gentle active range of motion among with muscle strengthening exercises was initiated immediately after surgery. A strict nonweight bearing protocol was recommended until the radiographs showed early callus mineralization (stage 1), after which partial weight bearing was allowed and gradually increased. Activities creating rotational torque such as kneeling, crossing the legs, and squatting were obviated but cycling and swimming were allowed. Repetitive or high impact activities were strictly prohibited.

2.2. Statistical Analysis {#sec2.2}
-------------------------

Student\'s *t*-test was performed using SPSS1 Version 22, 2013 (SPSS Inc., Chicago, IL, USA). Inter- and intraobserver variation was tested with Intraclass Correlation Coefficient (ICC 2.1) evaluating blinded radiographs.

The null hypothesis was that age, location, and chemotherapy did not affect ingrowth significantly. A *p* value less than 0.05 was considered to be statically significant.

3. Results {#sec3}
==========

The study included a total of 27 patients who completed the study. Group 2 was statistically younger than group 1 (*p* = 0.0003811). As we mentioned above a radiological assessment took place at every visit at preset time intervals (0 and 6 weeks and 3, 6, 9, 12, 15, and 18 months postoperatively). When defining the ingrowth stages there was neither interobserver nor intraobserver variability, ICC 2.1 consistency of 1.

Furthermore during the radiographic evaluation signs of loosening were sought as previously suggested in literature \[[@B6]\] fracture, transverse pin migration, and progressive radiolucency at the bone-prosthetic interface. The length of the visible part of the traction bar was measured and also the angle between the anchor and the spindle in order to exclude collapse, indicating loss of compression force. A fracture line was seen in this area in one patient after a fall at home one year after surgery. A diminished distance as well as an angulation between the spindle and the anchor plug was noted ([Figure 2](#fig2){ref-type="fig"}). The patient was closely observed: no fracture displacement was seen after one year, but the radiographic assessment showed no progression from stage 2 to stage 3.

For all patients stage 1 was generally reached at 6 months, stage 2 at 9 months, and stage 3 at 12 months. At 18 months all patients but three had reached stage 3. One of them has been just described above ([Figure 2](#fig2){ref-type="fig"}). Another one from group 2 showed progression and received longer chemotherapy and resection of pulmonary metastases. Interestingly, the third patient who was revised for an infected megaprosthesis using a Compress system reached stage 3 ingrowth by 18 months despite reinfection and two-time debridement. In one patient from group 1 palliative chemotherapy was started after 16 months after reaching stage 3. From the patients with remaining growing potential there was one child who had a revision of a long stem of the femur who did not receive chemotherapy.

There was neither stress shielding nor osteonecrosis nor transverse pin migration in this study. Other complications irrelevant to the study were also noted.

In our institution ultrasound is used for the local follow-up aiming at detection of local tumor recurrence in the proximity of large prosthetic implants. During the early stages an intense hypervascular aspect at the bone-prosthetic interface is observed. This phenomenon is also very distinct in a Technetium bone scan. Furthermore, callus formation should not be confused with heterotopic ossification, as seen in [Figure 3](#fig3){ref-type="fig"}.

The data were scrutinized in order to evaluate the effect of age and chemotherapy on the time interval on which patients reach the next stage of ingrowth. Statistically there was no significant difference between the two groups (*p* \> 0.05). Eventually the patients with still growing potential from group 2 were compared with the rest of the group and also group 1. A cut-off of 15 years at the time of surgery was chosen. The *p* values were still above 0.05. The null hypothesis was not rejected.

When the effect of chemotherapy and age were charted, it seemed that patients receiving chemotherapy generally reached stage 1 at a later time point (6 months instead of 3 months). When children were compared to young adults in the chemotherapy group, it seemed that children displayed a rebound ingrowth after cessation of chemotherapy resulting in a shorter period between stages 2 and 3 and reaching stage 3 at an earlier time point, as shown in [Figure 4](#fig4){ref-type="fig"}.

4. Discussion {#sec4}
=============

Dynamic compressive fixation of tumor prosthesis is a method introduced to the orthopedic surgery aiming to achieve biomechanical stable and durable implants while stimulating osseointegration. In literature there is currently no universal method describing bone remodeling and ingrowth following Compress fixation. Fracture callus measurement is also not an easy task \[[@B15]\] and is therefore not routinely used in daily practice. Avedian et al. \[[@B16]\] used digital calipers on standardized radiographs to measure the bone width. In our opinion this method is cumbersome and hard to reproduce when it comes to a multicenter research trial.

For this reason a new algorithm was proposed by the senior author of the group, which seems to be quite easy and straightforward. However, correct assessment of osseointegration also has a learning curve. When the ultrasound specialist is not familiar with the device, the image obtained during the development of the uncalcified callus may be misdiagnosed as a local recurrence due to the hypervascular aspect at the bone-prosthetic interface. The same is true for a Tc bone scan. Furthermore, callus formation should not be confused with heterotopic ossification as seen.

The authors have not observed the development of bone hypertrophy before stages 1 (early mineralization) and 2 (mature mineralization) have been reached. Apparently bone hypertrophy, a phenomenon observed at the periosteal side as well as at the endosteal side, is a slow continuous process, possibly starting at the same moment as the osseointegration, but this is hard to discern on radiographs. Full development of stage 3 was seen only in the femur but not in the tibia or in the humerus, which is a phenomenon we cannot explain.

We have observed a cessation of bone hypertrophy towards stage 3 after loss of compression force due to a fracture. This indicates the usefulness of a staged radiographic assessment for studying the influence of certain factors such as chemotherapy on the bone formation at the prosthetic interface. Although it is a small study and far from representative, we were able to demonstrate that, after the cessation of chemotherapy, progressive bone ingrowth is initiated. The negative effect of chemotherapy on bone metabolism has been well demonstrated in the literature. The impact of chemotherapy on graft healing was described in animal \[[@B19]--[@B22]\] and human \[[@B23]\] studies showing an increase of delayed union.

When it comes to osseointegration Avedian et al. observed a decrease in the absolute amount and the rate of bone hypertrophy in the group receiving chemotherapy. In our study we could demonstrate a trend towards a slower onset of stage 1 in patients receiving chemotherapy, but eventually almost all patients reach stage 3. Lack of significance is our opinion due to limited number of patients and diversity of the groups. Different local factors such as blood supply, preserving the intraosseous and small periosteal vessels, irrigation avoiding thermal necrosis, and soft tissue coverage are crucial elements during surgery. Osteonecrosis of the bone at the bone-Compress interface can be an important complication as mentioned by Healey et al. \[[@B7]\], but this phenomenon was not observed in our patient group.

5. Conclusion {#sec5}
=============

This paper describes a new methodology for the radiographic assessment of compressive osseointegration for the fixation of reconstruction prostheses after tumor resection. The application of the method is easy, allowing international comparison of prosthetic survival after Compress implantation. The authors propose to use this evaluation method also for studying factors delaying or preventing bone hypertrophy at the prosthetic interface such as age and chemotherapy regimen, causing prosthetic failure.
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![Radiographic stages of osseointegration according to the new assessment system.](BMRI2015-513939.001){#fig1}

![(a) and (b) Radiolucent line in the compress area after falling 1 y postop, (c) and (d) development of angulation and loss of distance between the anchor plug and the spindle can be observed after fracture (d) healing when compared to the prefracture X-ray (c). At 18 months stage 3 has not been reached (d).](BMRI2015-513939.002){#fig2}

![Heterotopic ossification seen at 6 months postop.](BMRI2015-513939.003){#fig3}

![Four graphs representing the effect of chemotherapy and age on the stage. (a) Patients not receiving chemotherapy. (b) Patients receiving chemotherapy demonstrate a long plateau stage 0 with delayed onset of bone formation at 6 months. When comparing the children and adults from this group (charts (c) and (d)) a rebound ingrowth and shorter period between stages 2 and 3 and reaching stage 3 earlier are observed.](BMRI2015-513939.004){#fig4}

###### 

Demographic information.

       Age at   Gender   Diagnosis                                                   Bone          Location   Type
  ---- -------- -------- ----------------------------------------------------------- ------------- ---------- ------------
  1    10       Female   3,5 years tumor-free, leg length discrepancy                Bone          Femur      Total knee
  2    31       Female   14 year tumor-free, femoral loosening                       Bone          Femur      Total knee
  3    33       Male     9 year tumor-free, infection                                Bone          Femur      Total knee
  4    41       Male     22 y tumor-free, loosening tumorprothese knee replacement                 Femur      Total knee
  5    40       Female   Leiomyosarcoma                                              Bone          Femur      Total knee
  6    65       Female   Leiomyosarcoma                                              Soft tissue   Femur      Total knee
  7    38       Male     Giant cell                                                  Bone          Femur      Total knee
  8    63       Female   Giant cell                                                  Bone          Femur      Total knee
  9    57       Female   Chondrosarcoma                                              Bone          Femur      Total knee
  10   68       Male     Chondrosarcoma                                              Bone          Femur      Total knee
                                                                                                              
  1    7        Male     Osteosarcoma                                                Bone          Femur      Total knee
  2    9        Female   Osteosarcoma                                                Bone          Femur      Total knee
  3    11       Male     Osteosarcoma                                                Bone          Femur      Total knee
  4    11       Female   Osteosarcoma                                                Bone          Femur      Total knee
  5    12       Male     Osteosarcoma                                                Bone          Femur      Total knee
  6    14       Female   Osteosarcoma                                                Bone          Femur      Total knee
  7    14       Female   Osteosarcoma                                                Bone          Femur      Total knee
  8    14       Male     Osteosarcoma                                                Bone          Femur      Total knee
  9    15       Female   Osteosarcoma                                                Bone          Femur      Total knee
  10   16       Male     Osteosarcoma                                                Bone          Femur      Total knee
  11   16       Female   Osteosarcoma                                                Bone          Femur      Total knee
  12   17       Female   Osteosarcoma                                                Bone          Femur      Total knee
  13   19       Male     Osteosarcoma                                                Bone          Femur      Total knee
  14   19       Female   Osteosarcoma                                                Bone          Femur      Total knee
  15   22       Male     Ewing sarcoma                                               Bone          Tibia      Total knee
  16   26       Male     Osteosarcoma                                                Bone          Femur      Total knee
  17   30       Female   Osteosarcoma                                                Bone          Femur      Total knee

###### 

The summary of the demographic characteristics of the two groups.

  Characteristic                                    Value
  ------------------------------------------------- -----------------------------------
  Number of patients                                27
  Compress fixed                                    27
  Follow-up                                         Mean 36 months (range 15--66)
  Male                                              12 (45.5%)
  Female                                            15 (55.5%)
  Age at surgery                                     
   Nonchemo                                         Mean 45, median 41 (range 10--65)
   Chemo                                            Mean 16, median 15 (range 9--30)
    *p* value                                       0.000377663
  Length of resection                                
   Nonchemo                                         Median 13.8 (range 8--23.5)
   Chemo                                            Median 15.3 (range 8--23.5)
    *p* value                                       0.303972
  Children (growing potential at surgery)           9 (33.3%)
  Adults treated with chemotherapy                  8 (29.6%)
  Adults not treated with chemotherapy              10 (37%)
  Diagnosis                                          
   Osteosarcoma                                     16 (59.2%)
   Ewing sarcoma                                    1 (3.7%)
   Chondrosarcoma, giant cell, and leiomyosarcoma   2 (7.4%)
  Revision                                           
   Loosening                                        2 (7.4%)
   3,5 years tumor-free, leg length discrepancy     1 (3.7%)
   9 year tumor-free, infection                     1 (3.7%)
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